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Summary
Background It has been hypothesized that early-life exposure to vaccinations, infections or
antibacterials influence allergic disease development. Concurrent exposure to grass pollens
may alter any effect.
Objective To test the hypothesis that exposure to antibacterials, vaccinations (DTP or MMR) or
specific infections during the first grass pollen seasons of life influences the risk of hayfever
more than at any other time of the year.
Methods Nested case–control studies were based on birth cohorts within two large databases
of computerized patient records from UK general practices: the General Practice Research
Database (GPRD) and Doctors’ Independent Network (DIN). Seven thousand ninety-eight
hayfever cases, diagnosed after age 2, were matched to controls for practice, age, sex and
follow-up of control to case ascertainment date. Conditional logistic regression was used to
compare exposure by age 1 (age 2 for MMR) inside vs. outside the grass pollen season
(May, June, July). Odds ratios (ORs) were pooled across databases.
Results There were no associations in either database between MMR during vs. outside the
grass pollen season and later hayfever. Of 23 infections studied, none were statistically
significant; although analyses for the less common conditions were limited by low statistical
power. The pooled OR for hayfever comparing exposure to antibacterials only in the grass
pollen season with only outside it was 1.20 (95% CI 0.98–1.47) and for DTP was 0.84 (95% CI
0.72–0.98).
Conclusion Although an interaction between early exposure to microbial agents and
concurrent grass pollen exposure on hayfever risk seemed plausible, there was little
evidence to support it across a range of analyses. However, the effect of DTP though weak
deserves further study.
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Introduction
The earliest grass pollen seasons of a child’s life are
potentially critical periods for the initiation and develop-
ment of pollen sensitization and hayfever. Previous epide-
miological studies have explored this by investigating
variations in the prevalence of pollen allergy by month
of birth, but the results have been inconsistent [1–7]. In
755 Japanese schoolchildren, the prevalence of allergic
rhinitis (AR) was significantly higher in those who were
born between August and October [4]. In 6535 10-year-
olds in Munich and Bavaria, those born in May had a 50%
increased risk of hayfever whereas those born in Novem-
ber were protected (40% reduced risk) [5]. In a study of
Derbyshire schoolchildren, there was no significant asso-
ciation between month of birth and hayfever prevalence,
although prevalence was the lowest for June and July
births [7]. More specifically, it has been hypothesized that
concurrent challenge to the immune system by pollens
and microbial agents early in life may inhibit proliferation
of T-helper type 2 (Th2) cell clones and thereby prevent
allergy [8]. In the only study to test this hypothesis
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epidemiologically, Strachan et al. [6] studied 11 765 ado-
lescent children in Sheffield, UK, and found no relation-
ship between infection in month 1 and the prevalence of
later hayfever in 960 June births.
Previously, we and others have exploited the potential
of large primary care databases to examine the role of
factors operating in the first year of life on the risk of
developing hayfever and asthma. The roles of routine
vaccination [9, 10], infectious illnesses [11] and antibac-
terials [11, 12] have been examined. Overall, the findings
have been negative; however, the possibility exists that
exposure to these agents during the grass pollen season
may induce different effects from exposure outside the
grass pollen season.
We therefore hypothesized that: (i) routine vaccination,
(ii) infectious illnesses presenting during the grass pollen
season or (iii) exposure to antibacterials during the grass
pollen season, indicating infectious illness at the time of
early allergen exposure, reduce the risk of subsequent
hayfever. We investigate these hypotheses using two large
UK-based primary care databases (PCDs): the General Prac-
tice Research Database (GPRD) and the Doctors’ Indepen-
dent Network (DIN) [13, 14]. The advantage of using these is
that the exposures and outcome are reliably recorded, the
results apply to the general population and the analyses are
based on large numbers of subjects. The latter is particularly
important when examining the interaction between micro-
bial agents and the grass pollen season.
Methods
We conducted nested case–control studies within a GPRD
cohort of 76 310 children born between 1989 and 1993
from 464 practices and within a DIN cohort of 40183
children born between 1989 and 1997 from 141 general
practices. All children had at least 5 years of follow-up
from birth and had been registered with the practice
within 3 months of birth. Background information on the
DIN database and the birth cohorts defined in GPRD and
DIN are published elsewhere [13, 14].
For each case of hayfever diagnosed, we selected
one control child, matched for general practice, sex,
birth month and follow-up of control to at least date
of diagnosis of case. A more detailed account can be
found in Bremner et al. [12]. Cases of hayfever were those
who had diagnostic codes and/or treatment for hayfever,
after 2 years of age. Children who were only diagnosed
before age 2 and not subsequently confirmed, or who only
ever had non-specific AR codes that did not exhibit
a seasonal pattern were excluded from being cases or
controls.
The advantages of using the two separate databases
were: (i) we could assess the consistency of results across
databases and (ii) pooling data from both databases
increased power. Pragmatically, we defined the grass
pollen season as May, June and July, although we recog-
nize that this varies according to location and annual
weather fluctuations [15]. May, June and July births are
likely to be exposed to two partial grass pollen seasons
in year 1.
We carried out three different matched case–control
analyses, all analysed by conditional logistic regression
using proc phreg in SAS version 8.1 [16]. In the first, we
considered: (i) only those pairs where both infants were
fully vaccinated to third DTP by month 12, exposure being
at least one dose within the grass pollen season vs. no
doses within the grass pollen season; (ii) only those
case–control pairs with both members vaccinated with
MMR by 24 months, with exposure being MMR within
vs. outside a pollen season. We excluded pairs where the
case and/or control were not exposed because such
non-exposed subjects may differ from those exposed in
important respects such as consultation behaviour, social
circumstances or family size.
In the second analysis, we explored a wide variety of
infections ranging from common, such as diarrhoea and
vomiting, to rare, such as threadworms, as defined in
DeWilde et al. [17]. As a control condition, we also
included behavioural problems in our selection, as these
are not uncommon and could not feasibly be related to the
risk of developing hayfever. We were interested in com-
paring the effect upon hayfever of infection only in a
grass pollen season vs. the same infection only outside a
grass pollen season. However, for many of the case–
control pairs where one child fell into one of these two
exposure groups, the other would either not be exposed at
all or be exposed in both periods. For example those
case–control pairs where one was exposed in the pollen
season and the other was not exposed at all provide an
estimate of pollen season exposure vs. no exposure.
Equally, other pairs where one was exposed outside the
pollen season and the other was not exposed provide an
estimate of non-pollen season exposure vs. no exposure.
Putting both estimates together gives an estimate of
pollen vs. non-pollen season exposure. Excluding all such
pairs would exclude the majority of subjects for certain
conditions, severely compromising statistical power. For
infections, we therefore based the analysis on all case–
control pairs.
In the third analysis, exposures to antibacterials in these
months were flagged. We then defined variables to code
exposure only in the grass pollen season, only outside it,
in both periods and in neither period of the first 12 months
of life. As with immunizations, the analysis was limited to
those case–control pairs where both were exposed to
antibacterials during the first year of life.
Odds ratios (ORs) were pooled across databases using a
fixed-effect model. This was carried out using the meta-
analysis command available for Stata [18, 19]. GPRD’s
c 2007 The Authors
Journal compilation c 2007 Blackwell Publishing Ltd, Clinical and Experimental Allergy, 37 : 512–517
Vaccinations, infections, antibacterials, grass pollen and risk of hayfever 513
Scientific and Ethics Advisory Group (SEAG) gave ethical
approval for our study.
Results
The cumulative incidence of hayfever in GPRD was 5.6%
and 7.3% in DIN. In GPRD, the cases were followed up for
a mean of 7.4 years, and the mean age of first diagnosis of
hayfever was 4.6 years. The corresponding figures in DIN
were 8.2 years of follow-up and a mean age of 5.1 years
at first diagnosis. Further details are available in Bremner
et al. [12]. In both our GPRD and our DIN cohorts, the
highest percentages of hayfever cases had been born in
March, April, May and June (around 9–10% in each of
these months). It should be noted that season of birth is
controlled for in our study design by matching of controls
to cases for date of birth.
To illustrate the level of exposure to the different
microbial agents by season, we give the total number of
cases plus controls in both cohorts (ignoring matching): (i)
not exposed, (ii) exposed only outside the grass pollen
season, (iii) exposed only within the grass pollen season
and (iv) exposed both in and outside the grass pollen
season as well as the percentage of cases plus controls
exposed (Table 1).
Vaccinations
In GPRD, 83.7% of case–control pairs received their third
DTP before age 1 and 94.7% received their MMR before
Table 1. Odds ratios of hay fever given exposure to antibacterials, DTP or infection (by 12 months) or MMR (by 24 months) in a grass pollen season vs.
outside one
Exposure
Totals (cases1controls)
Exposed (%)
Pooled across GPRD and DIN
Not out in both OR 95% CI P-value
DTPw by 12 months 2 018 6126 6 052 N/A 85.8 0.84 (0.72, 0.98) 0.02
MMRz by 24 months 673 9 690 3 833 N/A 95.3 1.05 (0.94, 1.18) 0.38
Infectionz by 12 months
Upper respiratory tract 7 510 4 667 799 1 220 47.1 1.02 (0.88, 1.19) 0.78
Conjunctivitis 9 676 3156 870 494 31.8 1.04 (0.89, 1.20) 0.65
Diarrhoea and vomiting 10 034 3 077 695 390 29.3 1.01 (0.86, 1.20) 0.86
Acute otitis media 11091 2 334 463 308 21.9 0.95 (0.78, 1.17) 0.65
Bronchitis and chest infection 12 018 1 668 302 188 15.2 1.17 (0.91, 1.49) 0.22
Candidiasis 11 783 1 660 604 149 17.0 1.02 (0.84, 1.23) 0.84
Viral illness 13175 737 242 42 7.2 0.97 (0.72, 1.30) 0.83
Fever/pyrexia 13 233 630 269 64 6.8 1.05 (0.78, 1.41) 0.73
Sore throat 13 438 553 171 34 5.3 0.88 (0.66, 1.17) 0.38
Bronchiolitis 13 329 767 69 31 6.1 0.86 (0.52, 1.42) 0.56
Laryngitis and croup 13 688 403 93 12 3.6 1.10 (0.70, 1.74) 0.67
Chickenpox 13 757 314 123 2 3.1 1.14 (0.74, 1.75) 0.55
Other viral rash 13 938 171 82 5 1.8 0.91 (0.54, 1.53) 0.72
Impetigo 14 016 128 47 5 1.3 1.64 (0.75, 3.59) 0.22
Otitis externa 14 069 87 37 3 0.9 0.50 (0.22, 1.10) 0.09
Chronic otitis media 14 076 95 24 1 0.8 0.74 (0.30, 1.84) 0.52
Measles 14 058 105 33 0 1.0 1.71 (0.76, 3.84) 0.20
Rubella 14 047 103 45 1 1.0 0.67 (0.33, 1.36) 0.26
Urinary tract infections 14 039 111 35 11 1.1 0.69 (0.35, 1.38) 0.30
Threadworms 14119 58 19 0 0.5 1.03 (0.36, 2.96) 0.96
Influenza 14 060 121 14 1 1.0 0.83 (0.27, 2.58) 0.75
Dermatophytosis 14120 60 15 1 0.5 0.56 (0.16, 1.98) 0.37
Abscess/boil/nail infection 14135 40 19 2 0.4 2.18 (0.65, 7.37) 0.21
Control condition
Behavioural problems 13 616 412 145 23 4.1 1.03 (0.70, 1.51) 0.88
Antibacterialsz by 12 months 5491 5618 740 2347 61.3 1.20 (0.98, 1.47) 0.07
For the vaccinations and antibacterials, case-control pairs were restricted to those where both had been exposed.
‘‘Not’’ exposed to antibacterials and vaccinations were not analysed but are presented for completeness.
wAny DTP dose in grass pollen season vs. none in grass pollen season.
zIn grass pollen season versus outside grass pollen season only.
Totals (cases1controls) = across GPRD and DIN; number in each exposure category, ignoring matching none = unexposed; out = exposed only outside
grass pollen season; in = exposed only inside grass pollen season; both = exposed both out- and inside grass pollen season.
GPRD, General Practice Research Database; DIN, Doctors’ Independent Network; OR, odds ratio; CI, confidence interval, N/A, not applicable.
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age 2. In DIN, the percentages were 88.8% and 96.1%. Our
analyses were restricted to the case–control pairs where
both received vaccination in the relevant time period.
Having any dose of DTP during the grass pollen season
(compared with DTP outside the grass pollen season) was
associated with a small reduction in the OR of hayfever
in both GPRD [OR= 0.87, 95% confidence interval (CI)
0.72–1.06] and in DIN (OR= 0.79, 95% CI 0.62–1.00) (Fig.
1) The fixed-effects pooled estimate was 0.84 (95% CI
0.72–0.98) (Table 1).
Receipt of MMR in a grass pollen season by age 24
months was associated with an increased OR of hayfever
in the GPRD (1.11) and a reduced OR in DIN (0.97) (Fig. 1).
Both the CI estimates included 1 and the fixed-effects
Figure 1. Risk of later hayfever, given exposure to vaccinations, infections and antibacterials (inside vs. outside the grass pollen season): (G) =General Practice
Research Database (D) =Doctors’ Independent Network odds ratio (log10 scale) of hayfever, given exposure to vaccinations, infections and antibacterials.
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model gave a combined estimate of 1.05, which was not
statistically significant (Table 1).
Infections
The prevalence of infections among all case–control pairs
ranges from 47% for URT to 0.4% for abscesses (Table 1).
As a result, the power for contrasting risk of exposure
within to outside the groups is limited for a number of the
infections. This is reflected in wider confidence limits for
the estimated ORs, particularly when analysing the two
databases separately (Fig. 1).
For some conditions, there was substantial variability
between the GPRD and DIN results (Fig. 1). For most
conditions, however, the overlap between the CIs was
large and, of the 23 infections plus behavioural problems
comparable in this way, in only seven instances did the
estimate from one database not lie within the 95% CI of
the other database. In 14 comparisons, one database
estimate was negative (ORo 1) and the other positive
(OR4 1). There was no tendency for one database to
consistently report higher ORs than the other (Fig. 1).
On pooling, most of the ORs were close to 1 (Table 1).
The CIs were wide for many of the conditions, even after
pooling. The only border line significant association with
hayfever was for otitis externa within compared with
outside the grass pollen season (pooled OR 0.50, 95% CI
0.22–1.10, P= 0.09).
Antibacterials
In GPRD, for cases and controls combined, 5.1% of
children were exposed to antibacterials only in a grass
pollen season, 17.9% were exposed both within and out-
with a grass pollen season, 40.3% were exposed only
outside and 36.7% were not exposed. In DIN, the percen-
tages were 5.4%, 14.5%, 38.6% and 41.5%.
Our analyses were restricted to the case–control pairs
where both members had received antibacterials in year 1
(43.6% in GPRD and 36.6% in DIN). The OR for exposure
within compared with outside the grass pollen season was
1.19, 95% CI 0.91–1.54) in GPRD and 1.22 (95% CI
0.89–1.67) in DIN (Fig. 1). The pooled OR was 1.20 (95%
CI 0.98–1.47) (Table 1).
Discussion
In two population-based birth cohorts, we have not
demonstrated any significant relationship between hayf-
ever and vaccination with MMR, with infections or use of
antibacterials relative to the grass pollen season. The
significant effect of DTP may be a chance finding, given
the large number of comparisons made, but given its
policy relevance it deserves further study.
In investigating exposure to early-life infections and
risk of subsequent atopic disease, some authors have
considered the total burden of infection [20–23]. We
decided not to define the total burden as we were
investigating such a broad range of conditions and
because of the difficulty of distinguishing new disease
episodes. While incident infections are easy to identify in
PCDs, recurrent diagnostic codes may not reflect new
disease occurrences.
Despite differences in coding conventions and data
structure, the two databases revealed similar results, instil-
ling greater confidence in the generalizability of our
conclusions. Compared with our earlier publications,
which examined the effect of exposure to antibacterials
or immunizations at any time in the first year of life vs.
not, the analyses presented here are less likely to be
confounded [10, 12]. This is because, unlike our earlier
studies, we are not comparing subjects exposed or not
exposed to a particular microbial agent, which may be
confounded with individual and family characteristics,
such as consultation behaviour. Rather, we are comparing
those exposed in different seasons. Such differences are
unlikely to be confounded by individual or family char-
acteristics.
We considered hayfever to be a suitable outcome to
investigate as it is undeniably atopic and the relevant
allergen exposure is confined to the spring and summer
months. Further, the crucial development period of the
immune system investigated here (largely year 1) and the
diagnosis of hayfever have substantial temporal separa-
tion. We carefully defined treated hayfever using specific
therapies and seasonal presentation, and believe the vast
majority of our cases to have hayfever. Criticism could be
levelled at our definition of the pollen season; some grass
pollens are still being released in August, a month that we
did not include in our definition of the pollen season, but
these are at much lower levels than in May, June and July
[24]. The effect of this would be a reduction in power to
detect an OR different to 1 for the comparison ‘exposed
only in the grass pollen season’ vs. ‘exposed only outside
the grass pollen season’.
Our study posed a well-defined question, with minimal
confounding, across a range of exposures that are central
to the ‘hygiene hypothesis’. While previous studies have
investigated early exposure to the agents we describe in
relation to hayfever, only one has addressed this interac-
tion with the pollen season [6]; few others would have had
sufficient statistical power to do so. Although the notion
of an interaction between microbial agents and the grass
pollen season on hayfever risk seemed plausible, there was
little evidence to support it across a range of analyses. We
conclude that previous studies that considered only all-
year exposures were not misleading. However, given its
policy relevance, the borderline effect of DTP deserves
further study.
c 2007 The Authors
Journal compilation c 2007 Blackwell Publishing Ltd, Clinical and Experimental Allergy, 37 : 512–517
516 S. A. Bremner et al
Acknowledgements
This work was funded by Wellcome Trust Grant 065177/
Z/01/Z.
Conflict of interest: N. R. is director of Cegedim Strate-
gic Data Ltd which markets DIN data to pharmaceutical
companies.
References
1 Aberg N. Birth season variation in asthma and allergic rhinitis.
Clin Exp Allergy 1989; 19:643–8.
2 Schafer T, Przybilla B, Ring J, Kunz B, Greif A, Uberla K.
Manifestation of atopy is not related to patient’s month of birth.
Allergy 1993; 48:291–4.
3 Sibbald B, Rink E. Birth month variation in atopic and non-
atopic rhinitis. Clin Exp Allergy 1990; 20:285–8.
4 Saitoh Y, Dake Y, Shimazu S et al. Month of birth, atopic disease,
and atopic sensitization. J Invest Allergol Clin Immunol 2001;
11:183–7.
5 Wjst M, Dold S, Reitmeir P, Stiepel E, von Mutius E. Month of
birth and allergic disease at the age of 10. Clin Exp Allergy 1992;
22:1026–31.
6 Strachan DP, Taylor EM, Carpenter RG. Family structure, neona-
tal infection, and hay fever in adolescence. Arch Dis Child 1996;
74:422–6.
7 Anderson HR, Bailey PA, Bland JM. The effect of birth month on
asthma, eczema, hayfever, respiratory symptoms, lung function,
and hospital admissions for asthma. Int J of Epidemiol 1981;
10:45–51.
8 Martinez FD. Role of viral infections in the inception of asthma
and allergies during childhood: could they be protective? Thorax
1994; 49:1189–91.
9 McKeever TM, Lewis SA, Smith C, Hubbard R. Vaccination and
allergic disease: a birth cohort study. Am J Public Health 2004;
94:985–9.
10 Bremner SA, Carey IM, DeWilde S et al. Timing of routine
immunisations and subsequent hay fever risk. Arch Dis Child
2005; 90:567–73.
11 McKeever TM, Lewis SA, Smith C et al. Early exposure
to infections and antibiotics and the incidence of allergic
disease: a birth cohort study with the West Midlands General
Practice Research Database. J Allergy Clin Immunol 2002; 109:
43–50.
12 Bremner SA, Carey IM, DeWilde S et al. Early-life exposure to
antibacterials and the subsequent development of hayfever in
childhood in the UK: case–control studies using the General
Practice Research Database and the Doctors’ Independent Net-
work. Clin Exp Allergy 2003; 33:1518–25.
13 Carey IM, Cook DG, DeWilde S et al. Developing a large
electronic primary care database (Doctors’ Independent Network)
for research. Int J Med Inform 2004; 73:443–53.
14 Carey I, Cook D, DeWilde S et al. Implications of the problem
orientated medical record (POMR) for research using electronic
GP databases: a comparison of the Doctors Independent Network
Database (DIN) and the General Practice Research Database
(GPRD). BMC Family Practice 2003; 4:14.
15 Emberlin J, Mullins J, Corden J et al. Regional variations in grass
pollen seasons in the UK, long-term trends and forecast models.
Clin Exp Allergy 1999; 29:347–56.
16 SAS Institute Inc. SAS System for SunOS, version 8.1. Cary, NC,
USA: SAS Institute Inc, 1999.
17 DeWilde S, Carey IM, Bremner SA et al. A comparison of the
recording of 30 common childhood conditions in the Doctors’
independent network and the general practice research data-
bases. Health Stat Quart 2004; 22:21–30.
18 Stata Corporation. Stata for Windows, version 8.0. College
Station, TX, USA: Stata Corporation, 1985-2003.
19 Sharp S, Sterne J. Sbe16: meta-analysis. Stata Techn Bull 1997;
38:9–14.
20 Bager P, Westergaard T, Rostgaard K, Hjalgrim H, Melbye M. Age
at childhood infections and risk of atopy. Thorax 2002;
57:379–82.
21 Benn CS, Melbye M, Wohlfahrt J, Bjorksten B, Aaby P. Cohort
study of sibling effect, infectious diseases, and risk of atopic
dermatitis during first 18 months of life. BMJ 2004; 328:1223.
22 Cullinan P, Harris JM, Taylor AJN et al. Can early infection
explain the sibling effect in adult atopy? Eur Respir J 2003;
22:956–61.
23 Paunio M, Peltola H, Virtanen M, Leinikki P, Makela A, Heinonen
OP. Acute infections, infection pressure, and atopy. Clin Exp
Allergy 2006; 36:634–9.
24 Emberlin J, Savage M, Jones S. Annual variations in grass pollen
seasons in London 1961–1990: trends and forecast models. Clin
Exp Allergy 1993; 23:911–8.
c 2007 The Authors
Journal compilation c 2007 Blackwell Publishing Ltd, Clinical and Experimental Allergy, 37 : 512–517
Vaccinations, infections, antibacterials, grass pollen and risk of hayfever 517
